Analyst firms · Morgan Stanley · ZION
Morgan Stanley ZION price target and rating history
Zions Bancorporation N.A. (ZION) · Finance
Morgan Stanley rates Zions Bancorporation N.A. (ZION) Underweight with a $77 price target, as of its latest action on Sep 8, 2026. It has published 5 rating actions on ZION since December 2022, including 2 upgrades and 2 downgrades. Across 5 firms with a ZION price target in the last 12 months, the median target is $75. Morgan Stanley's $77 is 3% above that.
- Current rating
- Underweight
- Price target
- $77
- Median target, all firms
- $75
- Actions on ZION
- 5
Morgan Stanley price target on ZION
Every Morgan Stanley rating on ZION
- Sep 8, 2026
- Mar 2, 2026
- Sep 30, 2024
- Sep 27, 2023
- Dec 5, 2022
How other firms rate ZION
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Robert W. Baird | Outperform | $75 | Oct 15, 2026 |
| UBS | Buy | $78 | Sep 14, 2026 |
| Morgan Stanley | Underweight | $77 | Sep 8, 2026 |
| Evercore ISI | In-line | $68 | Jul 23, 2026 |
| Stephens | Overweight | Jun 15, 2026 | |
| Brean Capital | Neutral | Mar 12, 2026 | |
| Jefferies | Buy | $60 | Nov 19, 2025 |
Questions about Morgan Stanley and ZION
- What is Morgan Stanley's price target for ZION?
- Morgan Stanley's latest stated price target for Zions Bancorporation N.A. (ZION) is $77, from its action on Sep 8, 2026.
- What is Morgan Stanley's rating on ZION?
- Morgan Stanley rates ZION Underweight, a bearish rating, as of Sep 8, 2026.
- When did Morgan Stanley last change its view on ZION?
- On Sep 8, 2026, Morgan Stanley downgrades to Underweight from Overweight, price target $77.
- How does Morgan Stanley's ZION target compare with other analysts?
- Across 5 firms with a ZION price target in the last 12 months, the median target is $75. Morgan Stanley's $77 is 3% above that.
More ZION rating histories
All Morgan Stanley ratingsZION news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.